We estimated the trajectory of CSF progranulin over 4 years of follow-up across the ATN group using linear mixed-effect models adjusted for the effect of age, sex, and APOE ε4 (Fig. 2A). The gene discussed is GRN; the disease is oculocutaneous albinism type 1.